home / stock / cnat / cnat quote
$0.556 Last:
0.18% Change Percent:
$0.59 Open:
$0.556 Previous Close:
$0.594 High:
$0.5406 Low:
1,638,707 Volume:
05/26/2020 04:46:22 am Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
Stock Date | Open Price | Close Price | High | Low | Volume |
---|---|---|---|---|---|
2020-05-26 | 0.59 | 0.556 | 0.594 | 0.5406 | 1,638,707 |
2020-05-25 | 0.63 | 0.555 | 0.63 | 0.525 | 3,043,177 |
2020-05-22 | 0.63 | 0.555 | 0.63 | 0.525 | 3,017,428 |
2020-05-21 | 0.66 | 0.58 | 0.75 | 0.4523 | 10,648,208 |
2020-05-20 | 0.688 | 0.6636 | 0.69 | 0.63 | 3,277,867 |
2020-05-19 | 0.64 | 0.67 | 0.72 | 0.6011 | 3,968,666 |
2020-05-18 | 0.602 | 0.645 | 0.66 | 0.5679 | 4,252,630 |
2020-05-15 | 0.6 | 0.6001 | 0.62 | 0.56 | 2,947,982 |
2020-05-14 | 0.5 | 0.626 | 0.66 | 0.49 | 8,031,946 |
2020-05-13 | 0.49 | 0.484 | 0.535 | 0.4515 | 3,392,913 |
2020-05-12 | 0.44 | 0.48 | 0.49 | 0.4134 | 3,908,074 |
2020-05-11 | 0.4153 | 0.43 | 0.4596 | 0.401 | 3,042,797 |
2020-05-08 | 0.402 | 0.4 | 0.4179 | 0.3602 | 2,375,155 |
2020-05-07 | 0.449 | 0.4574 | 0.515 | 0.4012 | 4,777,235 |
2020-05-06 | 0.5207 | 0.4399 | 0.54 | 0.4 | 5,886,170 |
2020-05-05 | 0.353 | 0.4726 | 0.498 | 0.3382 | 6,674,344 |
2020-05-04 | 0.345 | 0.3453 | 0.349 | 0.3329 | 67,252 |
2020-05-01 | 0.3598 | 0.342 | 0.3598 | 0.34 | 237,609 |
2020-04-30 | 0.3465 | 0.3565 | 0.3589 | 0.3333 | 206,779 |
2020-04-29 | 0.35 | 0.3499 | 0.352 | 0.3402 | 230,651 |
Conatus Pharmaceuticals Company Name:
CNAT Stock Symbol:
NASDAQ Market:
Conatus Pharmaceuticals Website:
News, Short Squeeze, Breakout and More Instantly...
SAN DIEGO, May 18, 2020 (GLOBE NEWSWIRE) -- Conatus Pharmaceuticals Inc. (Nasdaq:CNAT) today announced that Institutional Shareholder Services Inc. (ISS) and Glass Lewis, two leading independent research and proxy advisory firms that provide institutional investors with voting assessment an...
SAN DIEGO, May 14, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today the publication of data on HST 004, its patented, naturally-derived material for spinal disc repair ...
SAN DIEGO, May 11, 2020 (GLOBE NEWSWIRE) -- Histogen Inc., a regenerative medicine company with a novel biological platform that replaces and regenerates tissues in the body, announced today that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) app...